diallyl trisulfide has been researched along with Cancer of Ovary in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, H; Chen, X; Cui, Y; Huang, X; Ji, Y; Liu, L; Lou, Y; Wang, Z; Weng, Z; Wu, X; Yan, Y | 1 |
| Tu, S; Wan, FS; Wan, HF; Wu, JL; Yu, LH; Zhang, XL; Zhu, WF | 1 |
2 other study(ies) available for diallyl trisulfide and Cancer of Ovary
| Article | Year |
|---|---|
Diallyl trisulfide alleviates chemotherapy sensitivity of ovarian cancer via the AMPK/SIRT1/PGC1α pathway.
Topics: AMP-Activated Protein Kinases; Apoptosis; Cell Line, Tumor; Cisplatin; Female; Humans; Ovarian Neoplasms; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Sirtuin 1 | 2023 |
Effect of diallyl trisulfide on human ovarian cancer SKOV- 3/DDP cell apoptosis.
Topics: Allyl Compounds; Antineoplastic Agents; Antioxidants; Apoptosis; Apoptosis Regulatory Proteins; bcl-2-Associated X Protein; Blotting, Western; Cell Proliferation; Cisplatin; Drug Resistance, Neoplasm; Female; Flow Cytometry; Humans; Ovarian Neoplasms; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering; Sulfides; Tumor Cells, Cultured | 2013 |